Egnyte Announces Document Certification Service
Egnyte has announced a new document stamping service to certify and authenticate documents, files, reports, and content stored within the Egnyte repository.
With Egnyte’s document stamping service, a permanent, time-stamped record is created on the public blockchain with cryptographic proofs for documents, creating a digital record of authorship. This allows any authorized party to inspect and validate the document as it is certified without implicitly trusting vendor statements.
Read more about the new service here.
Rybrevant Plus Lazcluze Shows Over One-Year Survival Boost in EGFR-Mutated NSCLC Patients
January 7th 2025Results from the Phase III MARIPOSA trial demonstrated the combination of Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib) significantly improves overall survival compared to the current standard of care, Tagrisso (osimertinib), for patients with EGFR-mutated advanced or metastatic non-small cell lung cancer.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Addressing Racial Disparities in Lupus Clinical Trials
January 6th 2025Study finds that addressing racial disparities in lupus clinical trials requires targeted education, increased diversity among trial staff, culturally sensitive recruitment strategies, and addressing social determinants of health to improve Black patient participation.
